[{"Assets_0_Q2_USD":745081000.0,"CommonStockSharesOutstanding_0_Q2_shares":43798572.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":7535000.0,"NetIncomeLoss_1_Q2_USD":2738000.0,"NetIncomeLoss_2_Q2_USD":6185000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":45015720.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":44694745.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":43743356.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":43682650.0,"StockholdersEquity_0_Q2_USD":598659000.0,"EarningsPerShareBasic_1_Q2_USD":0.06,"EarningsPerShareBasic_2_Q2_USD":0.14,"EarningsPerShareDiluted_1_Q2_USD":0.06,"EarningsPerShareDiluted_2_Q2_USD":0.14,"Ticker":"RGEN","CIK":"730272","name":"REPLIGEN CORP","OfficialName":"Repligen Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8540516807.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]